Protein kinase ATP-binding pocket

The kinase ATP-binding pocket is a deep, highly conserved site located within the catalytic (active) domain of all protein kinases.[1][3][7] It resides in the cleft formed between the N-terminal and C-terminal lobes of the kinase domain and mediates the binding of ATP, enabling transfer of phosphate to substrate proteins during signaling.[1][3][7] This site is made up of several distinct subpockets lined by conserved residues, including the "hinge region" and catalytic residues. Most kinase inhibitors (type I and II) are designed to compete with ATP in this pocket, with drug selectivity often determined by leveraging structural differences in adjacent allosteric or hydrophobic pockets.[2][7][8] The ATP pocket is thus the primary pharmacological target in kinase drug discovery, particularly in cancer. However, therapeutic targeting is challenged by the pocket's high sequence conservation across the kinome, contributing to selectivity and toxicity issues. Because the "kinase ATP pocket" is a structural motif present in a large family of enzymes, it is not considered a unique molecular target, but rather a key druggable site shared by many kinases. If a unique target is required (e.g., "Epidermal growth factor receptor kinase ATP-binding site"), further specificity is necessary. The term "kinase ATP pocket" refers generically to an essential functional region, not to an individual gene/protein.

Other names

ATP-binding site (kinase)kinase active siteATP pocket

ATP-competitive inhibition (most kinase drugs bind in the ATP pocket to inhibit phosphorylation activity); Allosteric modulation (less common; many drugs access adjacent or overlapping pockets)